Aug 14, 2023 | Press Releases
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 14, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment...
Aug 11, 2023 | Press Releases
Transformational and accretive acquisition adds significant scale to INVO’s current operations Contributes over $5 million in incremental annual revenue as well as positive net income and cash flows First significant transaction establishing acquisitions as key...
Aug 9, 2023 | Press Releases
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Aug. 9, 2023 — INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment...
Aug 8, 2023 | Press Releases
SARASOTA, Fla., Aug. 8, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and...
Aug 4, 2023 | Press Releases
SARASOTA, Fla., Aug. 4, 2023 — INVO Bioscience, Inc. (Nasdaq:INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and...
Aug 3, 2023 | Press Releases
Company sets closing date deadline of acquisition to August 10, 2023 — Acquisition is expected to significantly enhance total annual revenue and contribute positive net income to the company’s operating results Transition to healthcare services company...
